Publications by authors named "Lin Xun"

Claim this Profile
R
Rehearsal-Free and Efficient Continual Learning for Cross-Domain Face Anti-Spoofing.
Rizhao Cai, Yawen Cui, Zitong Yu, Xun Lin, Changsheng Chen

IEEE Trans Pattern Anal Mach Intell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of Shi's cervical manipulation versus diclofenac for patients with acute and subacute neck pain: a multicenter clinical randomized trial.
Zhang Mingcai, Lin Xun, D U Guoqing, Liu Congying, Yuan Weian

J Tradit Chin Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study" [Eur J Cancer 213 (December) (2024) 115078].
Arun A Azad, Karim Fizazi, Nobuaki Matsubara, Fred Saad, Ugo De Giorgi, Xun Lin

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable and Balanced Transfer Learning for Generalized Multimodal Face Anti-Spoofing.
Xun Lin, Ajian Liu, Zitong Yu, Rizhao Cai, Shuai Wang

IEEE Trans Pattern Anal Mach Intell· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial.
Karim Fizazi, Arun A Azad, Nobuaki Matsubara, Joan Carles, André P Fay, Xun Lin

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial.
Neeraj Agarwal, Arun A Azad, Joan Carles, André P Fay, Nobuaki Matsubara, Xun Lin

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactively Fusing Global and Local Features for Benign and Malignant Classification of Breast Ultrasound Images.
Wenhan Wang, Jiale Zhou, Jin Zhao, Xun Lin, Yan Zhang

Ultrasound Med Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib plus enzalutamide versus placebo plus enzalutamide for patients with advanced prostate cancer and changes in specific DNA repair genes: a plain language summary of the results from the TALAPRO-2 study.
Karim Fizazi, Arun A Azad, Nobuaki Matsubara, Joan Carles, Andre P Fay, Xun Lin

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study.
Arun A Azad, Karim Fizazi, Nobuaki Matsubara, Fred Saad, Ugo De Giorgi, Xun Lin

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitrogen isotope characteristics and importance of NO from biomass burning in China.
Zanfang Jin, Jiawen Li, Qiang Yang, Yasheng Shi, Xun Lin

Sci Total Environ· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of the results from the TALAPRO-2 study: Talazoparib plus enzalutamide versus placebo plus enzalutamide for patients with advanced prostate cancer.
Neeraj Agarwal, Arun A Azad, Joan Carles, Andre P Fay, Nobuaki Matsubara, Xun Lin

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Shi-Style Steaming and Bathing Decoction in Patients with Knee Osteoarthritis: Study Protocol for a Randomized Placebo-Controlled Trial.
Ran Zhang, Ya-Jie Lei, Sheng-Yue Wen, Jian Pang, Yue-Long Cao, Xun Lin

J Pain Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposing image splicing traces in scientific publications via uncertainty-guided refinement.
Xun Lin, Wenzhong Tang, Haoran Wang, Yizhong Liu, Yakun Ju

Patterns (N Y)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.
Jiali Yu, Yijian Yan, Shasha Li, Ying Xu, Abhijit Parolia, Xun Lin

Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Karim Fizazi, Arun A Azad, Nobuaki Matsubara, Joan Carles, Andre P Fay, Xun Lin

Nat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the integration of sports and health industries drive the upgrade of the sports industry?-An empirical study based on Chinese-style modernization.
Jun Liu, Xun Lin, Fengwei Dong

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Karim Fizazi, Arun A Azad, Nobuaki Matsubara, Joan Carles, Andre P Fay, Xun Lin

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What learning strategies influence higher-order learning behaviours of medical students?
Jun Liu, Kaiwen Yuan, Xun Lin, Wenjia Zhu

Ann Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?
Maha Hussain, Cora N Sternberg, Eleni Efstathiou, Karim Fizazi, Qi Shen, Xun Lin

Future Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acupuncture for lumbar myofascial pain syndrome: systematic review and Meta-analysis.
Ran Zhang, Sheng-Yue Wen, Hong-Sheng Zhan, Xun Lin, Min Zhang

Zhongguo Zhen Jiu· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Neeraj Agarwal, Arun A Azad, Joan Carles, Andre P Fay, Nobuaki Matsubara, Xun Lin

Lancet· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of apolipoprotein E polymorphism on cerebral oxygen saturation, cerebral perfusion, and early prognosis after traumatic brain injury.
Xun Lin, Qilin Li, Xiaochuan Sun, Quanhong Shi, Wei Dan

Ann Clin Transl Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.
Maha Hussain, Cora N Sternberg, Eleni Efstathiou, Karim Fizazi, Qi Shen, Xun Lin

J Urol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggregation-Induced-Emission Photosensitizer-Loaded Nano-Superartificial Dendritic Cells with Directly Presenting Tumor Antigens and Reversed Immunosuppression for Photodynamically Boosted Immunotherapy.
Zhihong Sun, Jie Liu, Yueying Li, Xun Lin, Yongli Chu

Adv Mater· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which traits affect how long patients with advanced prostate cancer live when treated with enzalutamide?
Ugo De Giorgi, Maha Hussain, Neal Shore, Karim Fizazi, Bertrand Tombal, Xun Lin

Future Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis